PT1112747E - Vacina de salmonella que nao induz anticorpos contra flagelina ou flagelos - Google Patents
Vacina de salmonella que nao induz anticorpos contra flagelina ou flagelosInfo
- Publication number
- PT1112747E PT1112747E PT00204630T PT00204630T PT1112747E PT 1112747 E PT1112747 E PT 1112747E PT 00204630 T PT00204630 T PT 00204630T PT 00204630 T PT00204630 T PT 00204630T PT 1112747 E PT1112747 E PT 1112747E
- Authority
- PT
- Portugal
- Prior art keywords
- flagelos
- flageline
- antibodies against
- inducing antibodies
- salmonella vaccine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99204564 | 1999-12-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1112747E true PT1112747E (pt) | 2004-10-29 |
Family
ID=8241112
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT00204630T PT1112747E (pt) | 1999-12-28 | 2000-12-19 | Vacina de salmonella que nao induz anticorpos contra flagelina ou flagelos |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20010021386A1 (pt) |
| EP (1) | EP1112747B1 (pt) |
| JP (1) | JP5745731B2 (pt) |
| AT (1) | ATE269104T1 (pt) |
| AU (1) | AU783508B2 (pt) |
| BR (1) | BR0006291B1 (pt) |
| CA (1) | CA2329676A1 (pt) |
| DE (1) | DE60011560T2 (pt) |
| DK (1) | DK1112747T3 (pt) |
| ES (1) | ES2222152T3 (pt) |
| HU (1) | HU226192B1 (pt) |
| MX (1) | MXPA00012796A (pt) |
| PL (1) | PL206377B1 (pt) |
| PT (1) | PT1112747E (pt) |
| TR (1) | TR200401569T4 (pt) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4751570B2 (ja) * | 2002-09-11 | 2011-08-17 | 東レ・ダウコーニング株式会社 | オルガノポリシロキサン変性多糖類およびその製造方法 |
| CN101522210B (zh) | 2006-09-18 | 2017-03-22 | 阿肯色大学评议会 | 增强免疫应答的组合物和方法 |
| US7935355B2 (en) * | 2007-04-19 | 2011-05-03 | Nutritional Health Institute Laboratories, Llc | Composition and method for controlling intestinal pathogenic organisms |
| US20080260777A1 (en) * | 2007-04-19 | 2008-10-23 | Sotomayor Konky | Composition and method for controlling intestinal pathogenic organisms |
| CA2704457A1 (en) * | 2007-10-30 | 2009-05-07 | Walter Bottje | Compositions and methods of enhancing immune responses to flagellated bacterium |
| PL3097926T3 (pl) * | 2007-11-01 | 2020-04-30 | The Board Of Trustees Of The University Of Arkansas | Kompozycje i sposoby wzmacniania odpowiedzi odpornościowych na Eimeria |
| CA2703519C (en) | 2007-11-09 | 2017-04-18 | The Salk Institute For Biological Studies | Use of tam receptor inhibitors as immunoenhancers and tam activators as immunosuppressors |
| US8956618B2 (en) | 2010-01-21 | 2015-02-17 | The Texas A&M University System | Vaccine vectors and methods of enhancing immune responses |
| NZ702839A (en) | 2010-06-09 | 2016-04-29 | Univ Arkansas | Vaccine and methods to reduce campylobacter infection |
| KR101449417B1 (ko) | 2012-06-20 | 2014-10-27 | 한국외국어대학교 연구산학협력단 | 살모넬라 엔테리카의 박테리오파아지 및 그 용도 |
| RU2683027C2 (ru) | 2012-12-20 | 2019-03-26 | Заклад Бадавчо-Вдроженёвы Осьродка Сальмонельля "Иммуноляб" Сп. З О.О. | Поливалентная иммунизирующая и/или терапевтическая композиция для применения при бактериальных инфекциях или пищевом отравлении, в частности сальмонеллёзе, способ получения этой композиции, её применение и вакцина, содержащая эту композицию |
| SG11201506398SA (en) | 2013-02-14 | 2015-09-29 | Univ Arkansas | Compositions and methods of enhancing immune responses to eimeria or limiting eimeria infection |
| WO2014164607A1 (en) | 2013-03-11 | 2014-10-09 | The Brigham And Women's Hospital, Inc. | Vibro-based delivery system and immune suppression |
| JP6530742B2 (ja) | 2013-03-15 | 2019-06-12 | ザ ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ アーカンソー | 腸内病原体の免疫応答を強化する組成物及び方法 |
| AR108688A1 (es) | 2016-05-03 | 2018-09-19 | Univ Arkansas | Vector de vacuna de levadura que incluye polipéptidos inmunoestimuladores y antigénicos, métodos para su uso |
| CN111374094B (zh) * | 2020-03-02 | 2022-04-19 | 扬州大学 | 驴源马流产沙门氏菌经皮下致非妊娠期小鼠子宫感染模型的建立方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1109179A (en) * | 1964-09-30 | 1968-04-10 | Nat Res Dev | Improvements relating to typhoid and paratyphoid vaccines |
| EP0237045B1 (en) * | 1986-03-11 | 1993-10-20 | Shionogi & Co., Ltd. | DNA encoding flagellin and vector having the same |
| DE68922394T2 (de) * | 1988-05-05 | 1995-10-05 | Praxis Biolog Inc | Rekombinante vakzine von flagellin. |
| US6130082A (en) * | 1988-05-05 | 2000-10-10 | American Cyanamid Company | Recombinant flagellin vaccines |
| ES2070312T5 (es) * | 1988-12-19 | 2003-05-16 | American Cyanamid Co | Vacuna de proteina de membrana exterior meningococica de clase 1. |
| NZ281797A (en) * | 1994-02-18 | 1997-04-24 | Innovac Co | Inoculation of animals by inserting dried pelleted biological materials into the animal's ear |
| GB9621091D0 (en) * | 1996-10-09 | 1996-11-27 | Fondation Pour Le Perfectionem | Attenuated microorganisms strains and their uses |
| US6190669B1 (en) * | 1998-05-13 | 2001-02-20 | University Of Maryland, Baltimore | Attenuated mutants of salmonella which constitutively express the Vi antigen |
-
2000
- 2000-12-19 DK DK00204630T patent/DK1112747T3/da active
- 2000-12-19 DE DE60011560T patent/DE60011560T2/de not_active Expired - Lifetime
- 2000-12-19 AT AT00204630T patent/ATE269104T1/de active
- 2000-12-19 EP EP00204630A patent/EP1112747B1/en not_active Expired - Lifetime
- 2000-12-19 MX MXPA00012796A patent/MXPA00012796A/es active IP Right Grant
- 2000-12-19 PT PT00204630T patent/PT1112747E/pt unknown
- 2000-12-19 TR TR2004/01569T patent/TR200401569T4/xx unknown
- 2000-12-19 ES ES00204630T patent/ES2222152T3/es not_active Expired - Lifetime
- 2000-12-20 JP JP2000387225A patent/JP5745731B2/ja not_active Expired - Fee Related
- 2000-12-21 AU AU72453/00A patent/AU783508B2/en not_active Ceased
- 2000-12-27 CA CA002329676A patent/CA2329676A1/en not_active Abandoned
- 2000-12-27 US US09/749,025 patent/US20010021386A1/en not_active Abandoned
- 2000-12-27 BR BRPI0006291-0A patent/BR0006291B1/pt not_active IP Right Cessation
- 2000-12-27 HU HU0005010A patent/HU226192B1/hu not_active IP Right Cessation
- 2000-12-28 PL PL344851A patent/PL206377B1/pl not_active IP Right Cessation
-
2007
- 2007-10-30 US US11/980,864 patent/US20080069843A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| HU0005010D0 (pt) | 2001-02-28 |
| EP1112747A1 (en) | 2001-07-04 |
| PL344851A1 (en) | 2001-07-02 |
| PL206377B1 (pl) | 2010-08-31 |
| DK1112747T3 (da) | 2004-10-25 |
| MXPA00012796A (es) | 2002-05-23 |
| JP5745731B2 (ja) | 2015-07-08 |
| BR0006291B1 (pt) | 2014-02-18 |
| ATE269104T1 (de) | 2004-07-15 |
| AU783508B2 (en) | 2005-11-03 |
| EP1112747B1 (en) | 2004-06-16 |
| DE60011560T2 (de) | 2005-08-18 |
| HU226192B1 (en) | 2008-06-30 |
| CA2329676A1 (en) | 2001-06-28 |
| TR200401569T4 (tr) | 2004-07-21 |
| ES2222152T3 (es) | 2005-02-01 |
| US20010021386A1 (en) | 2001-09-13 |
| US20080069843A1 (en) | 2008-03-20 |
| HUP0005010A2 (en) | 2002-06-29 |
| AU7245300A (en) | 2001-07-05 |
| JP2001186874A (ja) | 2001-07-10 |
| BR0006291A (pt) | 2001-11-27 |
| DE60011560D1 (de) | 2004-07-22 |
| HUP0005010A3 (en) | 2004-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1112747E (pt) | Vacina de salmonella que nao induz anticorpos contra flagelina ou flagelos | |
| ATE556596T1 (de) | Regulierte attenuierung von lebendimpfstoffen zur verbesserung der kreuzimmunitätsschutzfunktion | |
| WO2006065553A3 (en) | Glycoconjugate vaccines containing peptidoglycan | |
| HUP0203056A1 (hu) | Vakcinakészítmény | |
| ATE426412T1 (de) | Adjuvante influenza-vakzine | |
| ATE542829T1 (de) | Impfstoff | |
| MY149604A (en) | C.perfringens alpha toxoid vaccine | |
| ATE346609T1 (de) | Kombinierte meningitis b/c impfstoffe | |
| ATE521621T1 (de) | Cpg-einzelstrang-desoxynukleotide zur verwendung als adjuvans | |
| CY1108178T1 (el) | Βακτηριο που προκαλει νοσο των πουλερικων και εμβολιο προερχομενο εξ' αυτου | |
| HUP0301634A2 (hu) | Hőmérséklet-érzékeny, élő vakcina Mycoplasma hyopneumoniaera | |
| DE60124526D1 (de) | Methode zur identifizierung von helicobacter antigenen | |
| MXPA02012857A (es) | Uso de una formulacion elaborada de o que contiene al menos un suero de leche dismilado. | |
| ATE270112T1 (de) | Streptococcus equi impfstoff | |
| SG147465A1 (en) | Vaccine | |
| ATE359815T1 (de) | Streptococcus-phocae-vakzine | |
| DK1074266T3 (da) | Levende svækkede bakterier til anvendelse i vaccine | |
| WO2005021031A3 (en) | Live attenuated bacterial vaccine | |
| CY1114309T1 (el) | Εμβολιο ροταϊου | |
| RU99117151A (ru) | Штамм бактерий pseudomonas aeruginosa 5002, используемый для изготовления вакцины против псевдомоноза пушных зверей | |
| RU99117152A (ru) | Штамм бактерий pseudomonas aeruginosa 4492, используемый для изготовления вакцины против псевдомоноза пушных зверей | |
| RU99117155A (ru) | Штамм бактерий pseudomonas aeruginosa 5292, используемый для изготовления вакцины против псевдомоноза пушных зверей | |
| RU99117153A (ru) | Штамм бактерий pseudomonas aeruginosa 4762, используемый для изготовления вакцины против псевдомоноза пушных зверей | |
| RU99117157A (ru) | Штамм бактерий pseudomonas aeruginosa ло3, используемый для изготовления вакцины против псевдомоноза пушных зверей | |
| RU99117154A (ru) | Штамм бактерий pseudomonas aeruginosa ло1, используемый для изготовления вакцин против псевдомоноза пушных зверей |